Abstract
Genetic disruption of Nrf2 greatly enhances susceptibility to prooxidant- and carcinogen-induced experimental models of various human disorders; but the mechanisms by which this transcription factor confers protection are unclear. Using Nrf2-proficient (Nrf2+/+) and Nrf2-deficient (Nrf2−/−) primary epithelial cultures as a model, we now show that Nrf2 deficiency leads to oxidative stress and DNA lesions, accompanied by impairment of cell-cycle progression, mainly G2/M-phase arrest. Both N-acetylcysteine and glutathione (GSH) supplementation ablated the DNA lesions and DNA damage–response pathways in Nrf2−/− cells; however only GSH could rescue the impaired colocalization of mitosis-promoting factors and the growth arrest. Akt activation was deregulated in Nrf2−/− cells, but GSH supplementation restored it. Inhibition of Akt signaling greatly diminished the GSH-induced Nrf2−/− cell proliferation and wild-type cell proliferation. GSH depletion impaired Akt signaling and mitosis-promoting factor colocalization in Nrf2+/+ cells. Collectively, our findings uncover novel functions for Nrf2 in regulating oxidative stress-induced cell-cycle arrest, especially G2/M-checkpoint arrest, and proliferation, and GSH-regulated redox signaling and Akt are required for this process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K, Yamamoto M . (2001). Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol 173: 154–160.
Bakkenist CJ, Kastan MB . (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499–506.
Bracken AP, Ciro M, Cocito A, Helin K . (2004). E2F target genes: unraveling the biology. Trends Biochem Sci 29: 409–417.
Buchold GM, Magyar PL, Arumugam R, Lee MM, O′Brien DA . (2007). p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis. Mol Reprod Dev 74: 997–1007.
Chan K, Kan YW . (1999). Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96: 12731–12736.
Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK et al. (2003). Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278: 703–711.
Cho H-Y, Jedlicka AE, Reddy SPM, Kensler TW, Yamamoto M, Zhang L-Y et al. (2002). Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175–182.
Cho HY, Reddy SP, Kleeberger SR . (2006). Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 8: 76–87.
Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y et al. (2006). S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 26: 2454–2461.
Conour JE, Graham WV, Gaskins HR . (2004). A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression. Physiol Genomics 18: 196–205.
Cross JV, Templeton DJ . (2004). Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 381: 675–683.
Dalle-Donne I, Carini M, Vistoli G, Gamberoni L, Giustarini D, Colombo R et al. (2007a). Actin Cys374 as a nucleophilic target of alpha, beta-unsaturated aldehydes. Free Radic Biol Med 42: 583–598.
Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A . (2007b). S-glutathionylation in protein redox regulation. Free Radic Biol Med 43: 883–898.
Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR . (2007). p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11: 191–205.
Fratelli M, Gianazza E, Ghezzi P . (2004). Redox proteomics: identification and functional role of glutathionylated proteins. Expert Rev Proteomics 1: 365–376.
Fratelli M, Goodwin LO, Orom UA, Lombardi S, Tonelli R, Mengozzi M et al. (2005). Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA 102: 13998–14003.
Gallogly MM, Mieyal JJ . (2007). Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381–391.
Gartel AL, Shchors K . (2003). Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283: 17–21.
Ghezzi P, Bonetto V, Fratelli M . (2005). Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 7: 964–972.
Golubnitschaja O . (2007). Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids 32: 359–371.
Helt CE, Cliby WA, Keng PC, Bambara RA, O′Reilly MA . (2005). Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J Biol Chem 280: 1186–1192.
Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313–322.
Kastan MB, Lim DS . (2000). The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1: 179–186.
Katayama K, Fujita N, Tsuruo T . (2005). Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. Mol Cell Biol 25: 5725–5737.
Kensler TW, Wakabayashi N, Biswal S . (2006). Cell survival responses to environmental stresses Via the Keap1–Nrf2–ARE pathway. Annu Rev Pharmacol Toxicol 47: 89–116.
Kim SS, Cao L, Lim SC, Li C, Wang RH, Xu X et al. (2006). Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol Cell Biol 26: 6983–6992.
King FW, Skeen J, Hay N, Shtivelman E . (2004). Inhibition of Chk1 by activated PKB/Akt. Cell Cycle 3: 634–637.
Kissel H, Georgescu MM, Larisch S, Manova K, Hunnicutt GR, Steller H . (2005). The Sept4 septin locus is required for sperm terminal differentiation in mice. Dev Cell 8: 353–364.
Klatt P, Lamas S . (2002). c-Jun regulation by S-glutathionylation. Methods Enzymol 348: 157–174.
Laine H, Doetzlhofer A, Mantela J, Ylikoski J, Laiho M, Roussel MF et al. (2007). p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis. J Neurosci 27: 1434–1444.
Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E et al. (2004). Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 173: 3467–3481.
Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K et al. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153–1160.
Lopez-Girona A, Furnari B, Mondesert O, Russell P . (1999). Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397: 172–175.
Louria-Hayon I, Grossman T, Sionov RV, Alsheich O, Pandolfi PP, Haupt Y . (2003). The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J Biol Chem 278: 33134–33141.
Marshall RP, Webb S, Hill MR, Humphries SE, Laurent GJ . (2002). Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 121: 68S–69S.
McAllister KA, Wiseman RW . (2002). Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related? Breast Cancer Res 4: 54–57.
Meloche S, Pouyssegur J . (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227–3239.
Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG . (2005). ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4: 1166–1170.
Nguyen T, Sherratt PJ, Pickett CB . (2003). Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43: 233–260.
Nigg EA . (2001). Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2: 21–32.
Niida H, Nakanishi M . (2006). DNA damage checkpoints in mammals. Mutagenesis 21: 3–9.
Nurse P . (1990). Universal control mechanism regulating onset of M-phase. Nature 344: 503–508.
Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M et al. (2008). Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303–1309.
Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M et al. (2002). Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol 4: 111–116.
Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M et al. (2006). Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21: 689–700.
Parra MT, Page J, Yen TJ, He D, Valdeolmillos A, Rufas JS et al. (2002). Expression and behaviour of CENP-E at kinetochores during mouse spermatogenesis. Chromosoma 111: 53–61.
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H . (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277: 1501–1505.
Putkey FR, Cramer T, Morphew MK, Silk AD, Johnson RS, McIntosh JR et al. (2002). Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E. Dev Cell 3: 351–365.
Qian X, Agematsu K, Freeman GJ, Tagawa Y, Sugane K, Hayashi T . (2006). The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system. Eur J Immunol 36: 906–918.
Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW et al. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248–1259.
Reddy NM, Kleeberger SR, Cho HY, Yamamoto M, Kensler TW, Biswal S et al. (2007a). Deficiency in Nrf2-GSH Signaling Impairs Type II Cell Growth and Enhances Sensitivity to Oxidants. Am J Respir Cell Mol Biol 37: 3–8.
Reddy NM, Kleeberger SR, Yamamoto M, Kensler TW, Scollick C, Biswal S et al. (2007b). Genetic dissection of the Nrf2-dependent redox signaling regulated transcriptional programs of cell proliferation and cytoprotection. Physiol Genomics 32: 74–81.
Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C et al. (2006). Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103: 13086–13091.
Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR . (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14: 2501–2514.
Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A, Bulbena O . (2007). Intratracheal transplantation of alveolar type II cells reverse bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 176: 1261–1268.
Shelton MD, Chock PB, Mieyal JJ . (2005). Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7: 348–366.
Shtivelman E . (2003). Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR. Mol Cancer Res 1: 959–969.
Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO et al. (2006). Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer. PLoS Med 3: e420.
Su TT . (2006). Cellular responses to DNA damage: one signal, multiple choices. Annu Rev Genet 40: 187–208.
Sugahara K, Tokumine J, Teruya K, Oshiro T . (2006). Alveolar epithelial cells: differentiation and lung injury. Respirology 11 (Suppl): S28–S31.
Taylor WR, Stark GR . (2001). Regulation of the G2/M transition by p53. Oncogene 20: 1803–1815.
Thimmulappa RK, Scollick C, Traore K, Yates M, Trush MA, Liby KT et al. (2006). Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-imidazolide. Biochem Biophys Res Commun 351: 883–889.
Timmers C, Sharma N, Opavsky R, Maiti B, Wu L, Wu J et al. (2007). E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 27: 65–78.
Townsend DM, Findlay VJ, Fazilev F, Ogle M, Fraser J, Saavedra JE et al. (2006). A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol Pharmacol 69: 501–508.
Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H et al. (2006). Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10: 241–252.
Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP . (2006). Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523–527.
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J . (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84.
Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS . (2007). Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46: 7765–7780.
Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S et al. (2003). Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35: 238–245.
Ward NE, Stewart JR, Ioannides CG, O′Brian CA . (2000). Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 39: 10319–10329.
Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku JK et al. (2003). Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17: 1201–1206.
Acknowledgements
This work was supported by NIH grants HL66109, ES11863 and SCCOR P50 HL073994 (to SPR), and NIEHS center grant P30 ES 038819. We acknowledge the help provided for FACS analysis by Becton Dickinson Immune Function Laboratory, Johns Hopkins Bloomberg School of Public Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Reddy, N., Kleeberger, S., Bream, J. et al. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene 27, 5821–5832 (2008). https://doi.org/10.1038/onc.2008.188
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.188
Keywords
This article is cited by
-
Identification of an integrated stress and growth response signaling switch that directs vertebrate intestinal regeneration
BMC Genomics (2022)
-
The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
Medical Oncology (2022)
-
Targeting Nrf2 may reverse the drug resistance in ovarian cancer
Cancer Cell International (2021)
-
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Molecular Neurodegeneration (2021)
-
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Oncogenesis (2017)